Amur Minerals Corporation (CRTX) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Amur Minerals Corporation (CRTX) has a cash flow conversion efficiency ratio of -0.663x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-1.19 Million ≈ $-145.12 USD) by net assets (GBX1.80 Million ≈ $218.77 USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Amur Minerals Corporation - Cash Flow Conversion Efficiency Trend (2016–2024)
This chart illustrates how Amur Minerals Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read CRTX liabilities breakdown for a breakdown of total debt and financial obligations.
Amur Minerals Corporation Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Amur Minerals Corporation ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Contango Holdings PLC
LSE:CGO
|
-0.024x |
|
Bradda Head Holdings Ltd
LSE:BHL
|
0.000x |
|
Mothercare PLC
LSE:MTC
|
0.109x |
|
Twenty One Capital, Inc.
NYSE:XXI
|
N/A |
|
Adomos SA
PA:ALADO
|
-0.008x |
|
Boostheat
PA:ALBOO
|
-8.082x |
|
The Investment Company plc
LSE:INV
|
-0.006x |
|
SPECTRA7 MICROSYSTEMS
F:7M0A
|
N/A |
Annual Cash Flow Conversion Efficiency for Amur Minerals Corporation (2016–2024)
The table below shows the annual cash flow conversion efficiency of Amur Minerals Corporation from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see Amur Minerals Corporation (CRTX) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | GBX1.48 Million ≈ $179.46 |
GBX-933.00K ≈ $-113.52 |
-0.633x | +5.83% |
| 2023-12-31 | GBX4.12 Million ≈ $501.77 |
GBX-2.77 Million ≈ $-337.03 |
-0.672x | -341.94% |
| 2022-12-31 | GBX23.13 Million ≈ $2.81K |
GBX-3.52 Million ≈ $-427.67 |
-0.152x | -84.33% |
| 2021-12-31 | GBX22.23 Million ≈ $2.70K |
GBX-1.83 Million ≈ $-223.02 |
-0.082x | +13.89% |
| 2020-12-31 | GBX22.93 Million ≈ $2.79K |
GBX-2.20 Million ≈ $-267.19 |
-0.096x | -31.63% |
| 2019-12-31 | GBX20.48 Million ≈ $2.49K |
GBX-1.49 Million ≈ $-181.30 |
-0.073x | +30.41% |
| 2018-12-31 | GBX23.49 Million ≈ $2.86K |
GBX-2.46 Million ≈ $-298.79 |
-0.105x | -4.61% |
| 2017-12-31 | GBX28.20 Million ≈ $3.43K |
GBX-2.82 Million ≈ $-342.93 |
-0.100x | -27.37% |
| 2016-12-31 | GBX25.58 Million ≈ $3.11K |
GBX-2.01 Million ≈ $-244.14 |
-0.078x | -- |
About Amur Minerals Corporation
CRISM Therapeutics Corporation develops a drug delivery technology for the clinical performance of cancer treatments for solid tumors through the local delivery of chemotherapy drugs. Its lead product is ChemoSeed, an implantable biodegradable drug delivery technology for the delivery of chemotherapy directly into cancer tissues. The company also offers formulation and consultancy services. The c… Read more